Crossmark

Proxy consent to clinical research participation: how should it be justified?

Crossref DOI link: https://doi.org/10.1007/s11019-026-10326-6

Published Online: 2026-02-14

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Sim, Julius https://orcid.org/0000-0002-1816-1676
Wrigley, Anthony https://orcid.org/0000-0001-8582-9915
License Information

Text and Data Mining valid from 2026-02-14

Version of Record valid from 2026-02-14
More Information

Article History

Received: 12 February 2025

Accepted: 24 January 2026

First Online: 14 February 2026

Declarations

:

: The authors declare that they have no competing interests.